Oura And Counsel Expand Partnership Through CMS ACCESS Model To Bring AI-Driven Chronic Care To Medicare Beneficiaries At Scale

The intersection of wearable health technology and federally backed healthcare delivery reached a significant milestone today with the announcement that smart-ring pioneer Oura is expanding its strategic partnership with AI-native primary care provider Counsel. This collaboration will leverage the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model. Designed to study the integration of continuous biometric data with physician-led medical interventions at a population scale, the initiative aims to fundamentally reshape how Medicare beneficiaries manage prevalent chronic conditions.

Beginning in early 2027, Counsel will roll out its specialized AI-native chronic care services at no out-of-pocket cost to eligible Medicare beneficiaries across nearly all United States jurisdictions. The program specifically targets individuals managing cardio-kidney-metabolic and related conditions, including hypertension, obesity, hyperlipidemia, and prediabetes. By fusing the continuous health tracking capabilities of the Oura Ring with Counsel’s hybrid model of advanced medical artificial intelligence and board-certified physicians, the partnership seeks to bridge the persistent gap between passive health monitoring and proactive clinical intervention for older Americans.

Chronology of the Collaboration and the CMS ACCESS Initiative

The genesis of this expanded healthcare delivery model traces back to May, when Oura and Counsel first joined forces to help Oura members transition smoothly from daily health insights to actionable clinical guidance. That initial integration allowed members to interpret continuous physiological signals captured by their wearable devices and consult with on-demand physicians who could contextualize these metrics. Early results from this integration proved highly encouraging, laying the groundwork for a broader, federally recognized deployment.

Members who utilized the initial integration and subsequently consulted a physician reported high levels of satisfaction, rating their care experience an impressive 4.6 out of 5. This feedback underscored the viability of pairing consumer-grade continuous data streams with responsive, high-quality telehealth and AI-assisted primary care. Recognizing the potential of this framework, the organizations sought a vehicle to scale the model.

The CMS Innovation Center’s ACCESS Model provided the ideal regulatory and operational framework for this expansion. Established to test innovative payment and service delivery models that preserve or enhance the quality of care while reducing program expenditures, the ACCESS program allows CMS to evaluate novel care delivery mechanisms. By integrating Oura and Counsel into this federal testing ground, the collaboration transitions from a direct-to-consumer wellness enhancement into an officially studied, scalable healthcare solution for the Medicare population.

Demographics, Data, and the Target Patient Population

The decision to deploy the ACCESS model through this specific technological partnership is rooted in compelling demographic data. Contrary to the common misconception that wearable technology is exclusively the domain of younger generations, older adults represent some of Oura’s most engaged users. Members aged 65 and older exhibit exceptionally high daily app engagement metrics, utilizing the platform consistently to monitor sleep, activity, and recovery metrics.

Furthermore, public health data within the Oura community highlights an urgent need for targeted chronic disease management in this cohort. Approximately 20 percent of Oura members aged 65 and older present with a Body Mass Index (BMI) of 30 or higher, placing them in the clinical category for obesity and elevating their risk for downstream complications such as type 2 diabetes, heart disease, and hypertension. By focusing the ACCESS program on hypertension, obesity, hyperlipidemia, and prediabetes, Counsel and Oura are directly addressing the most prevalent and costly chronic drivers within the Medicare demographic.

The operational mechanics of the program are designed to ensure seamless continuity. Oura will utilize its app infrastructure to inform eligible members about the ACCESS program and facilitate introductions to Counsel. Once an interested member expresses interest, Counsel’s clinical team will independently verify clinical eligibility, manage the formal enrollment process, and oversee ongoing patient care. Comprehensive enrollment guidelines and user interface pathways within the Oura App are slated to roll out progressively as the 2027 launch date approaches.

The Mechanics of AI-Native Primary Care and Biometric Integration

Under the expanded ACCESS framework, eligible Medicare beneficiaries will receive a multifaceted care experience that blends advanced technology with traditional medical expertise. Counsel’s platform relies on a dual-layer approach: a sophisticated medical artificial intelligence system that continuously analyzes patient inputs and provides personalized guidance, paired with immediate, on-demand access to human, board-certified physicians.

For participants who choose to wear the Oura Ring and consent to data sharing, the clinical equation changes significantly. Traditional primary care often relies on episodic data—snapshots of blood pressure, weight, and metabolic markers taken during routine, infrequent office visits. This model can miss subtle, daily fluctuations that signal declining health or the early onset of acute exacerbations.

By integrating continuous biometric health insights from the Oura App, Counsel physicians gain a longitudinal view of the patient’s daily physiological patterns. Metrics such as resting heart rate, heart rate variability, sleep architecture, and daily movement trends provide an objective backdrop against which clinical decisions can be made. This continuous data stream allows physicians to tailor therapeutic interventions more precisely, monitor patient adherence to lifestyle or pharmacological regimens in real time, and intervene before minor physiological shifts escalate into emergency medical events.

Executive Insights and Official Industry Reactions

Leadership from both organizations have emphasized the transformative potential of combining consumer health hardware with scalable clinical infrastructure. Industry analysts note that this partnership represents a maturing of the digital health sector, moving away from isolated wellness tracking and toward deeply integrated medical care models that cooperate with federal healthcare systems.

Addressing the strategic vision behind the initiative, Dr. Ricky Bloomfield, Chief Medical Officer at Oura, highlighted the transition from observation to treatment. Earlier in the year, Oura partnered with Counsel to help members move seamlessly from health insights to clinical action. Dr. Bloomfield noted that participating in the CMS ACCESS program provides an unprecedented opportunity to study that operational model at scale. It allows both organizations to better understand how continuous biometric data, when paired with proactive, physician-led care, can meaningfully support Medicare beneficiaries who are actively managing early cardio-kidney-metabolic conditions like hypertension and obesity.

Representatives from Counsel have similarly underscored the importance of matching the complexity of chronic disease management with equally sophisticated, accessible support systems. For millions of older Americans managing multiple overlapping health conditions, navigating the healthcare system can be overwhelming. The integration of AI-driven triage, on-demand telehealth, and passive biometric monitoring aims to reduce friction, eliminate out-of-pocket financial barriers, and foster a more connected, responsive healthcare relationship.

Broader Industry Implications and Future Outlook

The inclusion of consumer wearable data in a CMS Innovation Center model signals a potential paradigm shift in federal healthcare policy and chronic disease management. For years, the digital health industry has debated the clinical utility of consumer-grade wearables. While tech companies argued that continuous monitoring empowers patients, traditional healthcare systems frequently dismissed the data as unverified noise that could overwhelm clinical workflows.

By validating this model through the ACCESS program, CMS is signaling a growing openness to incorporating patient-generated health data into formal reimbursement and care delivery frameworks. If the study successfully demonstrates improved health outcomes, enhanced patient satisfaction, and optimized resource utilization, it could pave the way for broader regulatory acceptance and permanent reimbursement models for wearable-enabled remote patient monitoring across Medicare and commercial insurance lines.

For Oura, this partnership cements its transition from a hardware-focused consumer brand into an integral component of the digital health and clinical ecosystem. By demonstrating that its devices can drive measurable clinical value in vulnerable, high-cost populations, Oura positions itself advantageously in an increasingly crowded wearable market where healthcare integration is becoming the ultimate differentiator.

As preparations continue toward the early 2027 rollout, the healthcare industry will be watching closely. The success of the Oura and Counsel ACCESS initiative could serve as a blueprint for future public-private partnerships, proving that the fusion of artificial intelligence, continuous biometric monitoring, and human clinical expertise can successfully meet the complex demands of an aging population.